Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: FDC International Ltd, Unit 6 Fulcrum 1, Solent Way, Solent Business Park, Whiteley, Fareham Hampshire PO15 7FE, United Kingdom
Allercrom 2% w/v Eye Drops.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. A clear, colourless solution. Free from visible particulate matter. |
Active substance: Sodium cromoglicate (equivalent to 20.0 mg/ml anhydrous Sodium Cromoglicate).
[Sodium Cromoglicate 2.0% w/v]
Excipient(s) with known effect: Benzalkonium chloride 0.10 mg/ml
For the full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Cromoglicic acid |
Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
Low Density Polyethylene BFS bottles with a polystyrene spiked cap which contains 5 mL and 10 mL of Sodium Cromoglicate 2 % w/v Eye Drops solution.
Not all pack sizes may be marketed.
FDC International Ltd, Unit 6 Fulcrum 1, Solent Way, Solent Business Park, Whiteley, Fareham Hampshire PO15 7FE, United Kingdom
PL 15872/0008
16 May 2007 / 05 March 2012
| Drug | Countries | |
|---|---|---|
| ALLERCROM | Hong Kong, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
